Abstract
Small cell lung cancer (SCLC) presents multiple interdisciplinary challenges with several paradigm shifts in its treatment in recent years. SCLC treatment requires multidisciplinary management and timely treatment. The aim of this review is to focus on the team management aspects in the treatment of limited disease SCLC and how this can contribute towards improving outcomes.
Cite
CITATION STYLE
Glatzer, M., Rittmeyer, A., Müller, J., Opitz, I., Papachristofilou, A., Psallidas, I., … Putora, P. M. (2017). Treatment of limited disease small cell lung cancer: The multidisciplinary team. European Respiratory Journal, 50(2). https://doi.org/10.1183/13993003.00422-2017
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.